DK0820304T3 - Chlamydia-vacciner - Google Patents

Chlamydia-vacciner

Info

Publication number
DK0820304T3
DK0820304T3 DK96912001T DK96912001T DK0820304T3 DK 0820304 T3 DK0820304 T3 DK 0820304T3 DK 96912001 T DK96912001 T DK 96912001T DK 96912001 T DK96912001 T DK 96912001T DK 0820304 T3 DK0820304 T3 DK 0820304T3
Authority
DK
Denmark
Prior art keywords
chlamydial
vaccines
chlamydial vaccines
immunostimulants
mpl
Prior art date
Application number
DK96912001T
Other languages
Danish (da)
English (en)
Inventor
Jean-Paul Prieels
Moncef Mohamed Slaoui
Jean-Francois Maisonneuve
Vincent Verlant
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Application granted granted Critical
Publication of DK0820304T3 publication Critical patent/DK0820304T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/118Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK96912001T 1995-04-03 1996-04-01 Chlamydia-vacciner DK0820304T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9506863.1A GB9506863D0 (en) 1995-04-03 1995-04-03 Vaccines
PCT/EP1996/001463 WO1996031236A1 (en) 1995-04-03 1996-04-01 Chlamydia vaccines

Publications (1)

Publication Number Publication Date
DK0820304T3 true DK0820304T3 (da) 2000-08-28

Family

ID=10772426

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96912001T DK0820304T3 (da) 1995-04-03 1996-04-01 Chlamydia-vacciner

Country Status (23)

Country Link
EP (1) EP0820304B1 (de)
JP (2) JPH11503142A (de)
KR (1) KR19980703666A (de)
CN (1) CN1185740A (de)
AT (1) ATE193974T1 (de)
AU (1) AU700548B2 (de)
BR (1) BR9604853A (de)
CA (1) CA2215520C (de)
CZ (1) CZ313497A3 (de)
DE (1) DE69608959T2 (de)
DK (1) DK0820304T3 (de)
ES (1) ES2149466T3 (de)
GB (1) GB9506863D0 (de)
GR (1) GR3033764T3 (de)
HK (1) HK1008495A1 (de)
HU (1) HUP9801572A3 (de)
NO (1) NO974561L (de)
NZ (1) NZ306443A (de)
PL (1) PL322620A1 (de)
PT (1) PT820304E (de)
TR (1) TR199701113T1 (de)
WO (1) WO1996031236A1 (de)
ZA (1) ZA962616B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9626864D0 (en) * 1996-12-24 1997-02-12 Smithkline Beecham Biolog Vaccine
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
US6306404B1 (en) 1998-07-14 2001-10-23 American Cyanamid Company Adjuvant and vaccine compositions containing monophosphoryl lipid A
GB9819898D0 (en) * 1998-09-11 1998-11-04 Smithkline Beecham Plc New vaccine and method of use
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6635261B2 (en) 1999-07-13 2003-10-21 Wyeth Holdings Corporation Adjuvant and vaccine compositions containing monophosphoryl lipid A
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
CN101184504A (zh) * 2005-03-31 2008-05-21 葛兰素史密丝克莱恩生物有限公司 针对衣原体感染的疫苗
CN103068837B (zh) 2010-05-28 2015-06-24 斯匹遐生物技术公司 嵌合momp抗原、方法和使用
CN113940994B (zh) * 2021-11-09 2023-09-15 南华大学 壳聚糖-Pickering乳液白细胞介素12佐剂体系的制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9000207A (de) * 1990-01-29 1991-08-16 Duphar Int Res
AU666473B2 (en) * 1990-12-10 1996-02-15 Entremed, Inc A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis
CH682455A5 (fr) * 1991-07-25 1993-09-30 Serge Liotet Composition vaccinale.
JPH05339169A (ja) * 1992-03-03 1993-12-21 Dai Ichi Seiyaku Co Ltd 経口ワクチン
UA40597C2 (uk) * 1992-06-25 2001-08-15 Смітклайн Бічем Байолоджікалс С.А. Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів

Also Published As

Publication number Publication date
HUP9801572A2 (hu) 1998-10-28
NZ306443A (en) 1999-02-25
GB9506863D0 (en) 1995-05-24
PT820304E (pt) 2000-11-30
NO974561L (no) 1997-11-26
GR3033764T3 (en) 2000-10-31
AU700548B2 (en) 1999-01-07
CA2215520C (en) 2008-01-22
JPH11503142A (ja) 1999-03-23
ES2149466T3 (es) 2000-11-01
MX9707638A (es) 1998-06-28
EP0820304A1 (de) 1998-01-28
DE69608959D1 (de) 2000-07-27
JP2007308508A (ja) 2007-11-29
CA2215520A1 (en) 1996-10-10
BR9604853A (pt) 1998-06-16
CN1185740A (zh) 1998-06-24
EP0820304B1 (de) 2000-06-21
TR199701113T1 (xx) 1998-03-21
PL322620A1 (en) 1998-02-02
WO1996031236A1 (en) 1996-10-10
ATE193974T1 (de) 2000-07-15
ZA962616B (en) 1996-11-27
HK1008495A1 (en) 1999-05-14
KR19980703666A (ko) 1998-12-05
DE69608959T2 (de) 2000-11-16
HUP9801572A3 (en) 1999-04-28
AU5499996A (en) 1996-10-23
NO974561D0 (no) 1997-10-02
CZ313497A3 (cs) 1998-03-18

Similar Documents

Publication Publication Date Title
ES2186809T3 (es) Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso.
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
FR2814958B1 (fr) Composition vaccinale
NO991524L (no) Vaksiner
DK0820304T3 (da) Chlamydia-vacciner
ATE542829T1 (de) Impfstoff
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
DZ2283A1 (fr) Composition de vaccin.
NO972219D0 (no) Immunogenpreparater
ATE253641T1 (de) Antigenische präparationen
NL300336I1 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
ATE334697T1 (de) Boviner atmungs- und darmcoronavirus als impfstoff
FR2715304B1 (fr) Vaccin anti-allergique.
AU1825895A (en) Retroviral vaccines, vaccination and immune-therapy for retroviral infections
MX9100273A (es) Vacunas conjugadas en forma conjunta que comprenden proteina inmunogenica,peptidos relacionados con el hiv y porciones anionicas
ECSP961731A (es) Vacunas